Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshiaki Ishiguro is active.

Publication


Featured researches published by Yoshiaki Ishiguro.


Clinical and Experimental Hypertension | 2014

Febuxostat (Feburic tablet) in the management of hyperuricemia in a general practice cohort of Japanese patients with a high prevalence of cardiovascular problems

Shinya Hiramitsu; Yoshiaki Ishiguro; Hiroyuki Matsuyama; Kenji Yamada; Kazuo Kato; Manji Noba; Akihisa Uemura; Yoshirou Matsubara; Satoshi Yoshida; Atsushi Kani; Mamoru Tokuda; Hisashi Kato; Kazuo Hasegawa; Tatsushi Uchiyama; Shiro Matsubara; Kazuma Mori; Hisashi Kimura; Kenji Shino; Yasuchika Kato; Junichi Ishii

Abstract Hyperuricemia is increasing in prevalence and this is paralleled by an increased incidence of acute gout. In addition, there is growing evidence of an association between high serum levels of uric acid (sUA) and cardiovascular disease (CVD). In this preliminary report, we present 12–16 week results from a multicenter, general practice study in which we evaluated the usefulness of febuxostat in a cohort of untreated patients with hyperuricemia with a high prevalence of CVD. Febuxostat titrated from 10 mg/day up to 40 mg/day resulted in statistically significant and clinically relevant reductions in sUA after 12–16 weeks. A “responder” level of 6.0 mg/dL or lower was achieved in 95 of 100 (95%) patients. Significant reductions in sUA were achieved regardless of the presence/absence of coexisting diseases (e.g. CVD, renal insufficiency, diabetes and obesity) or the class of antihypertensive agent being used by the patient. No serious adverse reactions were noted with febuxostat. Although allopurinol has been used generally for hyperuricemia/gout, it is excreted fully via the kidneys, restricting its use in patients with reduced renal function, and its three-times-daily administration leads to poor adherence. Based on the results of this study, febuxostat may provide an easier option than allopurinol for clinicians specializing in CVDs.


Japanese Journal of Electrocardiology | 1992

Body surface distribution of ventricular late potentila evaluated by the signal-averaged ECG mapping. (I). Studies in patients with previous myocardial infarction.

Kazuo Kato; Hitoshi Hishida; Hitoshi Chikamatsu; Takeshi Shimaji; Atsushi Kani; Manji Noba; Tadashi Yasui; Hiroyuki Matsuyama; Yoshiaki Ishiguro; Yoshihiko Watanabe; Yasushi Mizuno

心筋梗塞症 (MI) における加算平均心電図 (SAEOG) の体表面分布を知るため, 発症後1ヵ月以上経過したMI93例 (前壁群50例: A群, 下壁群43例: I群) を対象とし, 胸背部28点よりSAECGマッピングを行い, 濾波後QRS時間 (fQRSd) の分布を検討した.各々の誘導点が有するアーチファクトや誘導部位の影響を除くため, 患者のfQRSdより健常対照11例のfQRSdの平均値を減じ, その値のばらつきの程度を標準偏差 (SD) に対する比で表し, departure ratio map (DR map) と命名した.DR mapの極大はA群, I群ともに前胸部から背部にかけて広く分布したが, A群で左胸部, I群で右胸部下部に2SD以上の極大と, 正領域に取り囲まれたように位置する負領域を有した例の心室頻拍 (VT) 合併率は有意に高かった.DR mapのかかる特定のパターンはVTの発生基盤に関係している可能性が示唆され, fQRSdの体表面分布を評価する場合, 延長領域ばかりでなくそれに囲まれた相対的短縮領域にも着目すべきことが示唆された.


Journal of Atherosclerosis and Thrombosis | 2010

The Effects of Ezetimibe on Surrogate Markers of Cholesterol Absorption and Synthesis in Japanese Patients with Dyslipidemia

Shinya Hiramitsu; Yoshiaki Ishiguro; Hiroyuki Matsuyama; Kenji Yamada; Kazuo Kato; Manji Noba; Akihisa Uemura; Satoshi Yoshida; Yoshiro Matsubara; Atsushi Kani; Kazuo Hasegawa; Hitoshi Hishida; Yukio Ozaki


Japanese Journal of Electrocardiology | 1993

Body surface distribution of ventricular late potential evaluated by the signal-averaged ECG mapping

Kazuo Kato; Hitoshi Hishida; Hitoshi Chikamatsu; Takeshi Shimaji; Atsushi Kani; Manji Noba; Tadashi Yasui; Hiroyuki Matsuyama; Yoshiaki Ishiguro; Yoshihiko Watanabe; Yasushi Mizuno


Japanese Circulation Journal-english Edition | 2009

PJ-578 Increasing of Cholesterol Absorption is a Critical Risk Factor Independent of Serum Cholesterol Level in Patients with or without Statins(PJ097,Cardiovascular Pharmacology (Clinical) (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

Kazuo Hasegawa; Shinya Hiramitsu; Yoshiaki Ishiguro; Hiroyuki Matsuyama; Kenji Yamada; Kazuo Katou; Manji Noba; Akihisa Uemura; Yoshiro Matsubara; Satoshi Yoshida; Atsushi Kani; Yukio Ozaki


Rinsho Yakuri\/japanese Journal of Clinical Pharmacology and Therapeutics | 1993

Electrophysiological Effects of a Single Oral Administration of Pentisomide (ME3202) in Patients with Supraventricular Tachycardia

Tadashi Yasui; Hitoshi Chikamatsu; Atsushi Kani; Manji Noba; Kazuo Kato; Yoshiaki Ishiguro; Takeshi Shimaji; Hiroyuki Matsuyama; Hitoshi Hishida; Yasushi Mizuno


Japanese Circulation Journal-english Edition | 1990

-0896-BODY SURFACE DISTRIBUTION OF FILTERED QRS DURATION IN ACUTE MYOCARDIAL INFARCTION AND ITS CORRELATION WITH VENTRICULAR ARRHYTHMIA : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY

Kazuo Kato; Hitoshi Hishida; Hitoshi Chikamatsu; Tadashi Yasui; Hiroyuki Matsuyama; Yoshiaki Ishiguro; Manji Noba; Atushi Kani; Takeshi Shimaji; Masanori Nomura; Yoshihiko Watanabe; Yasushi Mizuno


Japanese Circulation Journal-english Edition | 1989

DETECTION OF SILENT MYOCARDIAL ISCHEMIA BY SIMULTANEOUS RECORDING OF MAPPING ANBULATORY ECG AND POSTURAL INFORMATION : ECG, VCG, Mapping : 53 Annual Scientific Meeting, Japanese Circulation Society

Yoshiaki Ishiguro; Hitoshi Hishida; Hitoshi Chikamatsu; Tadashi Yasui; Hiroyuki Matsuyama; Manji Noba; Kazuo Katoh; Yasushi Mizuno; Toshiyuki Goto; Mitsuharu Okajima


Japanese Circulation Journal-english Edition | 1989

-316-INFLUENCE OF ACUTE ISCHEMIA ON EPICARDIAL POTENTIAL DISTRIBUTION AND VENTRICULAR ACTIVATION SEQUENCE IN DOGS : ECG, Mapping : FREE COMMUNICATIONS(II) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY

Manji Noba; Hitoshi Chikamatsu; Yoshiaki Ishiguro; Masato Ishihara; Hiroshi Nagai; Fumihiro Mitsuguchi; Hiroyuki Matsuyama; Tadashi Yasui; Yoshihiko Watanabe; Hitoshi Hishida; Yasushi Mizuno


Japanese Circulation Journal-english Edition | 1988

EXPERIMENTAL STUDY ON SIGNIFICANCE OF QRS AREA MAP : Comparison with VAT Map

Hitoshi Hishida; Hitoshi Chikamatsu; Hiroshi Kano; Tadashi Yasui; Hiroyuki Matsuyama; Yoshiaki Ishiguro; Yasushi Mizno

Collaboration


Dive into the Yoshiaki Ishiguro's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Manji Noba

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tadashi Yasui

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Atsushi Kani

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar

Kazuo Kato

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge